
The study investigates the combined effect of functional endoscopic sinus surgery (FESS) and mepolizumab versus mepolizumab alone in treating severe chronic rhinosinusitis with nasal polyps (CRSwNP). After 6 months, both groups showed improvements in SNOT-22 scores. However, patients with larger nasal polyp scores (6-8) had significantly greater improvements in SNOT-22, nasal polyp scores (NPS), and nasal congestion with the combination therapy.
Like
Save
Share